This trial studies how an adapted form of music therapy helps treat cisplatin induced tinnitus caused in patients with germ cell cancer that has come back (recurrent). An adapted form of music therapy called Modified Heidelberg Model of Neuro-Music Therapy (mHNMT) may reduce tinnitus and tinnitus associated distress.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT04402593.
PRIMARY OBJECTIVE:
I. To evaluate the feasibility of recruitment, retention, and compliance to a Modified Heidelberg Model of Neuro-Music Therapy (mHNMT) in patients with cisplatin-induced tinnitus (CIT) and relapsed germ cell cancer (rGCC) admitted to bone marrow transplant (BMT) service to undergo salvage high-dose chemotherapy with tandem bone marrow rescue.
SECONDARY OBJECTIVE:
I. To estimate the effects of mHNMT on severity of CIT, associated distress, anxiety, depression, fatigue, benefit findings, sleep, and audiometry measures and assess number of times homework completed.
OUTLINE:
Patients undergo music therapy over 60 minutes each for 6 sessions. Patients also wear an Actiwatch to track homework and sleep patterns.
Patients are followed up at 50, 100, 270 days post first music therapy visit.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationIndiana University/Melvin and Bren Simon Cancer Center
Principal InvestigatorDebra S. Burns
